Given the high cost (hundreds of millions) of taking a vaccine through clinical trials, FDA approval and production I'm curious why the choice to go the non-profit route. Is the growth plan to raise the money from large donors (Gates foundation, Wellcome Trust, etc.) or to licence the technology to more traditional pharma firms ?
Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
31–40 of 135 posts
Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#32I don't get it, isn't the point of investing to get the investment back in many multiples? How do you get your investment back if it's a non-profit?
I'm not an investor and this isn't tax advice!
Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#33I don't get it, isn't the point of investing to get the investment back in many multiples? How do you get your investment back if it's a non-profit?
I assume it's a tax dodge of some sort. I'm sure that investments in non-profits can be offset against capital gains (or something like that). I'm not an investor and this isn't tax advice!
Charitable donations do often result in reduced taxes. The catch is that the reduction in taxes is less than the donation (and at least in the U.S., there is no combination of State and Federal taxes that is greater than 100% of income...).
Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#34I'd like to understand why organisations like the Gates Foundation / NIH aren't excited by this approach? I'm assuming they've rejected this, which would explain the need to crowdfinance the next part. If they haven't rejected it, why aren't they being approached for grants? Also, where's the science? Having something in the FAQ that states "We're awaiting publication in a peer-reviewed journal" is, to be blunt, pret…
Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#35Earlier quoted context omitted.
Hi all, this is Naveen from Immunity Project YC team. The fact that we are using ML to identify epitopes that are the preferred targets on the virus for HIV controllers is key to what makes our project unique. This is a newer approach for developing a vaccine and therefore makes it "rogue."
This sounds pretty fascinating. Do you have any links/resources that dives more in depth into this approach?
Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#36Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#37I'd like to understand why organisations like the Gates Foundation / NIH aren't excited by this approach? I'm assuming they've rejected this, which would explain the need to crowdfinance the next part. If they haven't rejected it, why aren't they being approached for grants? Also, where's the science? Having something in the FAQ that states "We're awaiting publication in a peer-reviewed journal" is, to be blunt, pret…
In some other areas, the journals have more strictly policies, and don’t like preprints, reprints, free author pdf copies, ...
I’d really like to see a peer-review article, even if that means waiting to see the research data. There is a lot of bullshit inside per-review articles, but there is even more bullshit outside per-review articles. A per-review is not a guaranty that the article is correct, but at least it guaranty that some expert in that area had read the article and had no found any major fault.
Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#38Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#39I'm trying to understand what if any overlap a pharmaceutical nonprofit has with any value YC could add, from the scale of funds required, to product advice, to business model - everything seems entirely out of the range of YC's expertise.
Re: Startup developing HIV/AIDS vaccine is 2nd nonprofit accepted into Y Combinator
#40So have they developed a vaccine, but they need money for trials, delivery..? How exactly would they go about and test if it works on humans? Are there people who volunteer to get infected with HIV?
I'm Ian Cinnamon, one of the members of the Immunity Project YC team. We have in fact developed the vaccine. We've completed 2 years of animal testing, and we have one final experiment to run before we start our Phase I Clinical Trials in humans. In order to test the efficacy of the vaccine in human trials, we go to Durban, South Africa, where HIV has a prevalence rate of ~15%. We dose a wide range of healthy volunte…